CNOT8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.270850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.166000E-01
Normal-vs-Stage2
1.521560E-01
Normal-vs-Stage3
1.836200E-01
Normal-vs-Stage4
5.920200E-01
Stage1-vs-Stage2
9.984000E-01
Stage1-vs-Stage3
3.155800E-01
Stage1-vs-Stage4
6.625800E-01
Stage2-vs-Stage3
2.725200E-01
Stage2-vs-Stage4
5.992200E-01
Stage3-vs-Stage4
3.626000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.244810E-01
Normal-vs-AfricanAmerican
2.910200E-01
Normal-vs-Asian
2.392400E-01
Caucasian-vs-AfricanAmerican
8.425200E-01
Caucasian-vs-Asian
4.223000E-01
AfricanAmerican-vs-Asian
8.017000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.491010E-01
Normal-vs-Female
1.216400E-01
Male-vs-Female
9.624600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.545600E-01
Normal-vs-Age(41-60Yrs)
4.159400E-01
Normal-vs-Age(61-80Yrs)
6.799700E-02
Normal-vs-Age(81-100Yrs)
3.439800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.500200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.027400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.441600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.433500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.897910E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.005200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.230000E-01
Normal-vs-Daily Drinker
1.622580E-01
Normal-vs-Weekly Drinker
2.378300E-02
Normal-vs-Occasional Drinker
3.489200E-01
Normal-vs-Social Drinker
1.735170E-01
Non Drinker-vs-Daily Drinker
7.856800E-01
Non Drinker-vs-Weekly Drinker
6.892300E-02
Non Drinker-vs-Occasional Drinker
5.052000E-01
Non Drinker-vs-Social Drinker
8.624800E-01
Daily Drinker-vs-Weekly Drinker
1.044960E-01
Daily Drinker-vs-Occasional Drinker
3.604400E-01
Daily Drinker-vs-Social Drinker
6.598400E-01
Weekly Drinker-vs-Occasional Drinker
1.802420E-02
Weekly Drinker-vs-Social Drinker
3.313900E-02
Occasional Drinker-vs-Social Drinker
6.230400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.746000E-02
Normal-vs-Grade 2
1.077060E-03
Normal-vs-Grade 3
2.138900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.704440E-03
Grade 1-vs-Grade 3
5.317200E-03
Grade 1-vs-Grade 4
3.746000E-02
Grade 2-vs-Grade 3
9.082000E-01
Grade 2-vs-Grade 4
1.077060E-03
Grade 3-vs-Grade 4
2.138900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.487700E-02
Normal-vs-NonDiabetic
1.289400E-01
Diabetic-vs-NonDiabetic
4.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.467000E-01
Normal-vs-NoPancreatitis
1.203640E-01
Pancreatitis-vs-NoPancreatitis
2.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.336620E-01
Normal-vs-N1
1.491030E-01
N0-vs-N1
8.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.600000E-01
Normal-vs-TP53-NonMutant
1.519830E-01
TP53-Mutant-vs-TP53-NonMutant
2.379900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
